Facile synthesis of N-α-Boc-1,2-dialkyl-L-histidines: Utility in the synthesis of Thyrotropin-Releasing Hormone (TRH) analogs and evaluation of the CNS activity

Journal of Heterocyclic Chemistry

Volumn 45, Issue 6, 2008, Pages 1603-1608

  Monga, Vikramdeep ^a   Lal Meena, Chhuttan ^a   Kaur, Navneet ^a   Kumar, Satyendra ^a   Pawar, Chandrashekhar ^a   Sharma, Shyam Sunder ^a   Jain, Rahul ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; HISTIDINE DERIVATIVE; IODINE DERIVATIVE; PENTOBARBITAL; PROTIRELIN; PROTIRELIN DERIVATIVE;

ALKYLATION; ARTICLE; ASYMMETRIC SYNTHESIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL STRUCTURE; DECARBOXYLATION; HORMONE SYNTHESIS; IN VIVO STUDY; MOTOR ACTIVITY; OXIDATION; SLEEP TIME; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 57749085557     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570450608     Document Type: Article

References (44)

1. Eggen, M.; Nair, S. K.; Georg, G. I. Org. Lett. 2001, 12, 1813.
2. White, J. D. J. Org. Chem. 1999, 64, 6206.
3. Kojima, Y.; Watanabe, M.; Seki, Y.; Yamato, K.; Miyake, H. Chem. Lett. 1995, 797.
4. Oishi, S.; Karki, R. G.; Kang, S.; Wang, X.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke Jr, T. R. J. Med. Chem. 2005, 48, 764.
5. Gante, J. Angew. Chem. Int. Ed. 1994, 33, 1699
6. Hurby, V. J.; Al-Obeidi, F.; Kazmierski, W. Biochem. J. 1990, 268, 249
7. Hong, S. Y.; Oh, J. A.; Kwon, M.; Choi, M. J.; Lee, J. H.; Lee, B. L.; Moon, H. M.; Lee, K. H. Antimicrob. Agents Chemother. 1998, 42, 2534.
8. Frankel, A.; Li, S.; Starck, S. R.; Roberts, R. W. Curr. Opin. Struct. Biol. 2003, 13, 506.
9. Steer, D. L.; Lew, R. A.; Perlmutter, P.; Smith, A. I.; Aguilar, M-I. Curr. Med. Chem. 2002, 9, 811.
10. Cody, W. L.; He, J. X.; Reily, M. D.; Haleen, S. J.; Walker, D. M.; Reyner, E. L.; Stewart, B. H.; Doherty, A. M. J. Med. Chem. 1997, 40, 2228.
11. Hocart, S. J.; Jain, R.; Murphy, W. A.; Taylor, J. E.; Morgan, B.; Coy, D. H. J. Med. Chem. 1998, 41, 1146.
12. Hocart, S. J.; Jain, R.; Murphy, W. A.; Taylor, J. E.; Coy, D. H. J. Med. Chem. 1999, 42, 1863.
13. Hurby, V. J. Nature Rev. Drug. Dis. 2002, 1, 847.
14. Lindskog, S. Pharmacol. Ther. 1997, 74, 1.
15. Boler, J.; Enzmann, F.; Folkers, K.; Bowers, C. Y.; Schally, A. V. Biochem. Biophys. Res. Commun. 1969, 37, 705.
16. Brownstein, M.; Palkovits, M.; Saavedra, R.; Bassiri, R.; Utiger, R. Science 1974, 185, 267.
17. Horita, A.; Carino, M. A.; Lai, H. Ann. Rev. Pharmacol. Toxicol. 1986, 26, 311.
18. White, S. R.; Crane, G. K.; and Jackson, D. A. Ann. N. Y. Acad. Sci. 1989, 553, 337.
19. Griffiths, E. C. Clin. Sci. 1987, 73, 449.
20. Kelly, J. A. Essays Biochem. 1995, 30, 133.
21. Prokai, L., Prokai-Tatrai, K.; Zharikova, A.; Nguyen, V.; Perjesi, P.; Stevens, S. M. J. Med. Chem. 2004, 47, 6025.
22. Duthie, S. M.; Taylor, P. L.; Anderson, L.; Cook, J.; Eidne, K.A. Mol. Cell. Endocrinol. 1993, 95, R11.
23. Cao, J.; O'Donnell, D.; Vu, H.; Payza, K.; Pou, C.; Godbout, C.; Jakob, A.; Pelletier, M.; Lembo, P.; Ahmad, S.; Walker, P. J. Bol. Chem. 1998, 273, 32281.
24. de la Pena, P.; Delgado, L. M.; del Camino, D.; Barros, F. J. Biol. Chem. 1992, 267, 25703.
25. Itadani, H.; Nakamura, T.; Itoh, J.; Iwaasa, H.; Kanatani, A.; Borkowski, J.; Ihara, M.; Ohta, M. Biochem. Biophys. Res. Comm. 1998, 250, 68.
26. Sun, Y.; Lu, X.; Gershengorn, M. C. J. Mol. Endocrinology 2003, 30, 87.
27. Kaur, N; Lu, X; Gershengorn, M. C.; Jain, R. J. Med. Chem. 2005, 48, 6162.
28. Kaur, N.; Monga, V.; Josan, J. S.; Lu, X.; Gershengorn, M. C.; Jain, R. Bioorg. Med. Chem. 2006, 14, 5981.
29. Jain, R.; Cohen, L. A. Tetrahedron 1997, 53, 4539.
30. Kaur, N.; Monga, V.; Jain, R. Tetrahedron Lett. 2004, 45, 6883.
31. Minisci, F.; Bernardi, R.; Berlin, F.; Galli, R.; Perchinummo, M. A. Tetrahedron 1971, 27, 3575.
32. Minisci, F.; Vismara, E.; Fontana, F. Heterocycles 1989, 28, 489.
33. Jain, R.; Cohen, L. A. Tetrahedron 1997, 53, 2365.
34. The optical purity of N-α-Boc-1,2-dialkyl-L-histidines 8a-b was assessed on HPLC using CHIRALPAK WH chiral column (ID 0.46 cm, particle size 10μm), and results indicate presence of ≤1.5% of the D-enatiomer.
35. Wu, J.; Yoon, S. H.; Wu, W. M.; Bodor, N. J. Pharm. Pharmacol. 2002, 54, 945.
36. Barker, J. L.; Ransom, B. R. J. Physiol. 1978, 280, 355.
37. Mathers, D. A.; Barker, J. L. Science 1980, 209, 507.
38. Chu, Q. P.; Wang, L. E.; Cui, X. Y.; Fu, H. Z.; Lin Z. B.; Lin, S. Q.; Zhang Y. H. Pharmacol. Biochem. Behav. 2007, 86, 693.
39. O'Beirne, M.; Gurevich, N.; Carlen, P. Can. J. Physiol. Pharmacol. 1987, 65, 36.
40. Sirois, J. E.; Pancrazio, J. J.; Bayliss, D. A. J. Physiol. 1998, 512, 851.
41. Kalivas, P.W.; Simasko, S.M.; Horita, A. Brain Res. 1981, 222, 253.
42. Yarbrough, G. G. Trends Pharmacol. Sci. 2003, 24, 617.
43. Nillni, E. A.; Sevarino, K.A. Endocr. Rev. 1999, 20, 599.
44. Bernard, P. S.; Bennet, D. A.; Pastor, G.; Yokoyama, N.; Liebman, J. M. J. Pharmacol. Exp. Ther. 1995, 235, 98.